PTC Therapeutics Inc (PTCT)
42.96
-0.22
(-0.51%)
USD |
NASDAQ |
Nov 07, 16:00
43.00
+0.04
(+0.09%)
Pre-Market: 20:00
PTC Therapeutics Revenue (TTM): 900.45M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 900.45M |
| March 31, 2024 | 927.56M |
| December 31, 2023 | 937.82M |
| September 30, 2023 | 798.18M |
| June 30, 2023 | 818.73M |
| March 31, 2023 | 770.45M |
| December 31, 2022 | 698.80M |
| September 30, 2022 | 696.62M |
| June 30, 2022 | 618.23M |
| March 31, 2022 | 569.38M |
| December 31, 2021 | 538.59M |
| September 30, 2021 | 492.22M |
| June 30, 2021 | 471.89M |
| March 31, 2021 | 430.45M |
| December 31, 2020 | 380.77M |
| September 30, 2020 | 358.36M |
| June 30, 2020 | 311.37M |
| March 31, 2020 | 321.66M |
| December 31, 2019 | 306.98M |
| September 30, 2019 | 296.86M |
| June 30, 2019 | 279.03M |
| March 31, 2019 | 262.26M |
| December 31, 2018 | 264.73M |
| September 30, 2018 | 256.43M |
| Date | Value |
|---|---|
| June 30, 2018 | 244.69M |
| March 31, 2018 | 223.91M |
| December 31, 2017 | 194.39M |
| September 30, 2017 | 141.55M |
| June 30, 2017 | 122.69M |
| March 31, 2017 | 90.36M |
| December 31, 2016 | 82.70M |
| September 30, 2016 | 70.25M |
| June 30, 2016 | 57.04M |
| March 31, 2016 | 48.18M |
| December 31, 2015 | 36.77M |
| September 30, 2015 | 37.92M |
| June 30, 2015 | 28.94M |
| March 31, 2015 | 23.58M |
| December 31, 2014 | 25.25M |
| September 30, 2014 | 18.66M |
| June 30, 2014 | 33.32M |
| March 31, 2014 | 37.77M |
| December 31, 2013 | 34.70M |
| September 30, 2013 | 33.31M |
| June 30, 2013 | 23.90M |
| March 31, 2013 | 24.10M |
| December 31, 2012 | 28.78M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
306.98M
Minimum
Dec 2019
937.82M
Maximum
Dec 2023
597.29M
Average
569.38M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Pfizer Inc | 59.37B |
| Vertex Pharmaceuticals Inc | 10.63B |
| BridgeBio Pharma Inc | 219.12M |
| Cassava Sciences Inc | -- |
| Crinetics Pharmaceuticals Inc | -- |